...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

narmac

Rank: Vice President [?]

Points: 3973 [?]

Votes: 36 Score: 3.0 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

News!!! IND Clearance for ZEN-3694!

posted on Mar 18, 2019 09:09AM

Zenith Epigenetics Announces U.S. FDA Clearance of Investigational New Drug Application for ZEN-3694 in TNBC Program.

https://www.globenewswire.com/news-release/2019/03/18/1756353/0/en/Zenith-Epigenetics-Announces-U-S-FDA-Clearance-of-Investigational-New-Drug-Application-for-ZEN-3694-in-TNBC-Program.html

4 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply